Merck & Co., Inc: Hypertension trials
The registry lists 33 Hypertension studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 27 have results posted.
Phase 1 17Phase 2 5Phase 3 9No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)CompletedNCT04945460Phase 2Results posted
- A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)CompletedNCT04896008Phase 3Results posted
- Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)TerminatedNCT04811092Phase 3Results posted
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)CompletedNCT01656408Phase 1Results posted
- A Single Rising Dose Study of MK-8150 (MK-8150-001)CompletedNCT01590810Phase 1Results posted
- A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)CompletedNCT01446003Phase 1Results posted
- A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)CompletedNCT01370655Phase 1Results posted
- Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)CompletedNCT01337674Phase 1Results posted
- MK-0954E Study in Participants With Hypertension (MK-0954E-357)CompletedNCT01302691Phase 3Results posted
- MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)CompletedNCT01299376Phase 3Results posted
- Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003)CompletedNCT01263314Phase 1Results posted
- Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)CompletedNCT01244035Phase 1Results posted
- The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)CompletedNCT01130168Phase 1Results posted
- A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)CompletedNCT01104545Phase 1Results posted
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)CompletedNCT01096667Phase 2Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)CompletedNCT01096160Phase 1Results posted
- A Multiple Dose Study of MK-3614 (MK-3614-002)CompletedNCT01033643Phase 1Results posted
- Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)CompletedNCT01025843Phase 1Results posted
- A Single Dose Study of MK-8266 (MK-8266-001)CompletedNCT01025791Phase 1Results posted
- MK0954 Versus Placebo for Treatment of Mild to Moderate HypertensionCompletedNCT00888355Phase 3Results posted
- A Study to Investigate the Antihypertensive Efficacy of MK0954CompletedNCT00887250Phase 3Results posted
- A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)CompletedNCT00886600Phase 3Results posted
- A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)CompletedNCT00882440Phase 3Results posted
- Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)CompletedNCT00871871Phase 1Results posted
- Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)TerminatedNCT00806585Phase 2Results posted
- A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)CompletedNCT00789321Phase 1Results posted
- Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)CompletedNCT00274716Phase 2Results posted
- A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)CompletedNCT01033318Phase 1
- The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)CompletedNCT00856960Phase 1
- Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)CompletedNCT00811226
- Antihypertensive Response to Losartan and Genetic PolymorphismsCompletedNCT00617877Not applicable
- A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)CompletedNCT00543413Phase 2
- Hyzaar Asia HEAALTH (0954A-950)CompletedNCT00354991Phase 3